Mumbai-Arizona strategy for the US market
Mumbai’s Piramal Critical Care (PCC) has formed a strategic partnership with US-based pharmaceutical outsourcing facility, #Medivant Healthcare of Arizona, to help address the severe shortage of injectable drugs in hospitals across the United States.
Through this partnership, PCC and Medivant Healthcare will work together to distribute single-dose injectable drugs in approved states for COVID-19 patients that have fallen dangerously short in supply.
Piramal has a marketing and sales team with a strong footprint across the United States, serving nearly all hospitals and surgical facilities nationwide.
“Our partnership with Medivant Healthcare will leverage our robust nationwide US marketing and distribution capabilities that will enable the supply of single-dose injectable products to critical and sensitive markets for immediate use,” said Peter DeYoung, Chief Executive Officer, Piramal Critical Care.
“In the last few months with the disruption caused by the pandemic, we have observed that there has been an acute shortage of certain key injectable drugs in the US,” he said on 22 July 2020.
“We are happy to enter an important partnership with Piramal Critical Care amidst a global healthcare crisis,” said Founder and Director of Medivant Healthcare, Viraj Gandhi.
“Coupling our focus on producing critical shortage medications with PCC’s extensive market reach, I am confident that together we will play an integral role in helping hospitals across the country alleviate these acute drug shortages,” said Gandhi.
#Piramal Critical Care, a business unit of Piramal Enterprises Limited (PEL), is a global leader in anesthesia, pain management, and intrathecal therapy. It maintains a wide presence across more than 100 countries including the US and the European markets.
PEL also has a strong presence in the Indian financial services sector. PEL is listed on the #BSE Limited and the National Stock Exchange of India Limited in India.
Medivant Healthcare is one of the USA’s newest outsourcing facilities focused on providing hospitals & doctors’ offices with single-dose sterile injectable drugs on the US FDA’s Drug Shortage List. #pharmaceuticals #medical #medicines #hospitals #FDA /fiinews.com
